Rare diseases are rapidly becoming a high priority therapeutic area for our industry. This is needed, especially when fewer than 5% of approx 7,000 rare diseases have drug therapies available, and many of these provide limited benefit. There is also a business case to this, due to a supportive reimbursement environment, particularly in the US. […]

Read More →

Rare disease drug development is a rapidly expanding field with growing pressure for getting more orphan drug approved to treat rare diseases. There is a vast consensus among patients, health care bodies, governments etc. to expedite drug development in this field. Some wonderful numbers that attest to growing interest in rare diseases and orphan drugs […]

Read More →

Exploring the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies, requires considering many factors and areas. In first part of this series of article for Clinical Trials in United States, regulatory situation, site and investigators were discussed. In this part, we will be knowing about […]

Read More →

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum. Globally, colorectal cancer is the third most common type of cancer in both men and women making up about 10% of all cases. Currently, there is a significant focus on development of drugs for […]

Read More →

Gastro-Intestinal (GI) drugs market is a potentially huge market with many different indications, drug types and treatment regimens. Transparency Market Research and PRNewswire reports predict the global GI drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. While, it was worth USD 46.5 Billion in 2016, it […]

Read More →

Alopecia is a condition in which hairs are lost from some or all areas of the body. In fact, alopecia areata is also known as spot baldness for this reason. Most commonly, patients have bald spots on their scalps about the size of a coin. There are three (3) well-known types of Alopecia Alopecia areata […]

Read More →

Acute vestibulopathy is characterized by an acute or subacute onset of vertigo, dizziness or imbalance with or without ocular motor, sensory, postural or autonomic symptoms and signs, and can last for seconds to up to several days.1 What is Acute Unilateral Vestibulopathy? Normal vestibular end organs generate an equal resting-firing frequency of the axons, which […]

Read More →

Best reasons to conduct clinical trials in any country include availability of patients, clarity of regulatory processes, willing and qualified investigators and a sound infrastructure with a reasonable cost. This is what you get if you conduct clinical trials in Romania. Let’s see this in greater details. Brief Demography Romania is a sovereign state located in Southeastern Europe […]

Read More →

Poland is regarded as one of the largest clinical trials markets in CEE/CIS. In a report in 2010, PriceWaterHouseCoopers (PwC) pointed that with 469 new clinical trials registrations in 2009, Poland accounted for c. 2.5%-3.0% of the world market by registration volumes. Current Status of Clinical Research in Poland Status of clinical research has degraded over […]

Read More →

Identification and selection of clinical sites and investigator remains one of the first and most important decisions that trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site / investigator identification on clinical trial successes time and […]

Read More →